Effects of angiotensin receptor blocker, Candesartan on renal function in type 2 diabetes with chronic kidney disease and hypertensio
Phase 4
- Conditions
- type 2 diabetes with chronic renal disease and hypertention
- Registration Number
- JPRN-UMIN000002049
- Lead Sponsor
- Juntendo University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
the patients who are not satisfied with key inclusion criteria.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method eGFR 1 year after intervention
- Secondary Outcome Measures
Name Time Method IMT, blood pressure (ratio of achievement in BP 130/80mmHg) urinary secretion of albumin, 1 year after intervention